HEADER TRANSCRIPTION 06-OCT-08 3ET3 TITLE STRUCTURE OF PPARGAMMA WITH 3-[5-METHOXY-1-(4-METHOXY- TITLE 2 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: STEROID RECEPTOR COACTIVATOR 1; COMPND 9 CHAIN: P; COMPND 10 FRAGMENT: RESIDUES 681-696; COMPND 11 SYNONYM: NCOA-1, NUCLEAR RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 12 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 13 EC: 2.3.1.48; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: NCOA1, SRC1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET-28 KEYWDS PPAR, PPARG, PPARGAMMA, DRUG DISCOVERY, DIABETES, ADIPONECTIN, KEYWDS 2 METABOLIC DISEASE, FRAGMENT-BASED DRUG DISCOVERY, SCAFFOLD-BASED KEYWDS 3 DRUG DISCOVERY, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, KEYWDS 4 DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, KEYWDS 5 PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION KEYWDS 6 REGULATION, ZINC, ZINC-FINGER, ACYLTRANSFERASE, CHROMOSOMAL KEYWDS 7 REARRANGEMENT, PROTO-ONCOGENE, TRANSFERASE, UBL CONJUGATION EXPDTA X-RAY DIFFRACTION AUTHOR K.Y.J.ZHANG,W.WANG REVDAT 2 06-SEP-23 3ET3 1 REMARK SEQADV REVDAT 1 17-FEB-09 3ET3 0 JRNL AUTH D.R.ARTIS,J.J.LIN,C.ZHANG,W.WANG,U.MEHRA,M.PERREAULT,D.ERBE, JRNL AUTH 2 H.I.KRUPKA,B.P.ENGLAND,J.ARNOLD,A.N.PLOTNIKOV,A.MARIMUTHU, JRNL AUTH 3 H.NGUYEN,S.WILL,M.SIGNAEVSKY,J.KRAL,J.CANTWELL, JRNL AUTH 4 C.SETTACHATGULL,D.S.YAN,D.FONG,A.OH,S.SHI,P.WOMACK,B.POWELL, JRNL AUTH 5 G.HABETS,B.L.WEST,K.Y.ZHANG,M.V.MILBURN,G.P.VLASUK, JRNL AUTH 6 K.P.HIRTH,K.NOLOP,G.BOLLAG,P.N.IBRAHIM,J.F.TOBIN JRNL TITL SCAFFOLD-BASED DISCOVERY OF INDEGLITAZAR, A PPAR PAN-ACTIVE JRNL TITL 2 ANTI-DIABETIC AGENT JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 262 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19116277 JRNL DOI 10.1073/PNAS.0811325106 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 20354 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.230 REMARK 3 FREE R VALUE TEST SET COUNT : 1065 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.0974 - 3.8997 0.93 2422 123 0.1653 0.1923 REMARK 3 2 3.8997 - 3.0954 0.97 2416 142 0.1695 0.2389 REMARK 3 3 3.0954 - 2.7041 0.98 2424 138 0.1952 0.2610 REMARK 3 4 2.7041 - 2.4568 0.98 2423 125 0.1924 0.2512 REMARK 3 5 2.4568 - 2.2807 0.99 2410 129 0.1791 0.2726 REMARK 3 6 2.2807 - 2.1463 0.99 2402 146 0.1825 0.2504 REMARK 3 7 2.1463 - 2.0388 0.99 2364 147 0.1859 0.2722 REMARK 3 8 2.0388 - 1.9500 0.99 2428 115 0.2118 0.2584 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 64.68 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.24660 REMARK 3 B22 (A**2) : 9.10630 REMARK 3 B33 (A**2) : -7.85970 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2288 REMARK 3 ANGLE : 0.924 3083 REMARK 3 CHIRALITY : 0.065 354 REMARK 3 PLANARITY : 0.003 387 REMARK 3 DIHEDRAL : 15.033 878 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 30.4425 32.9042 75.7804 REMARK 3 T TENSOR REMARK 3 T11: 0.2289 T22: 0.2043 REMARK 3 T33: 0.1841 T12: -0.0261 REMARK 3 T13: -0.0158 T23: 0.0034 REMARK 3 L TENSOR REMARK 3 L11: 1.4539 L22: 1.9586 REMARK 3 L33: 2.3477 L12: 0.3174 REMARK 3 L13: 0.2746 L23: 0.6750 REMARK 3 S TENSOR REMARK 3 S11: -0.0456 S12: 0.1589 S13: 0.0003 REMARK 3 S21: -0.1759 S22: 0.1263 S23: 0.0410 REMARK 3 S31: 0.2135 S32: 0.1915 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3ET3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049732. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-03 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22003 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 61.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05100 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28800 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PURIFIED PPARG LBD PROTEIN WAS REMARK 280 DILUTED TO 12 MG/ML AND 1MM OF INDEGLITAZAR AND 2X MOLAR EXCESS REMARK 280 OF SRC-1 PEPTIDE WERE ADDED PRIOR TO CRYSTALLIZATION BY MIXING REMARK 280 EQUAL VOLUMES OF PROTEIN/COMPOUND SAMPLE WITH RESERVOIR SOLUTION REMARK 280 CONTAINING 27% POLYETHYLENE GLYCOL (PEG) 4000, 0.1 M 2-(BIS-(2- REMARK 280 HYDROXY-ETHYL)-AMINO)-2-HYDROXYMETHYL- PROPANE-1,3-DIOL (BISTRIS) REMARK 280 BUFFER AT PH 6.5, 0.2 M AMMONIUM ACETATE, AND 5% GLYCEROL, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.06750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.06750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.42650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.33550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 26.42650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.33550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.06750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.42650 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.33550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.06750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 26.42650 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 43.33550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 186 REMARK 465 GLY A 187 REMARK 465 SER A 188 REMARK 465 SER A 189 REMARK 465 HIS A 190 REMARK 465 HIS A 191 REMARK 465 HIS A 192 REMARK 465 HIS A 193 REMARK 465 HIS A 194 REMARK 465 HIS A 195 REMARK 465 SER A 196 REMARK 465 SER A 197 REMARK 465 GLY A 198 REMARK 465 LEU A 199 REMARK 465 VAL A 200 REMARK 465 PRO A 201 REMARK 465 ARG A 202 REMARK 465 GLY A 203 REMARK 465 SER A 204 REMARK 465 HIS A 205 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 240 38.87 -91.90 REMARK 500 GLU A 259 22.50 -67.65 REMARK 500 LYS A 358 -73.68 -10.38 REMARK 500 THR A 459 56.56 -141.94 REMARK 500 THR A 461 -114.16 -68.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ET1 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ET0 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARGAMMA WITH 3-(5-METHOXY-1H-INDOL-3-YL)-PROPIONIC REMARK 900 ACID REMARK 900 RELATED ID: 3ET1 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARALPHA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID REMARK 900 RELATED ID: 3ET2 RELATED DB: PDB REMARK 900 STRUCTURE OF PPARDELTA WITH 3-[5-METHOXY-1-(4-METHOXY- REMARK 900 BENZENESULFONYL)-1H-INDOL-3-YL]-PROPIONIC ACID DBREF 3ET3 A 207 477 UNP P37231 PPARG_HUMAN 235 505 DBREF 3ET3 P 680 695 UNP Q15788 NCOA1_HUMAN 680 695 SEQADV 3ET3 MET A 186 UNP P37231 EXPRESSION TAG SEQADV 3ET3 GLY A 187 UNP P37231 EXPRESSION TAG SEQADV 3ET3 SER A 188 UNP P37231 EXPRESSION TAG SEQADV 3ET3 SER A 189 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 190 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 191 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 192 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 193 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 194 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 195 UNP P37231 EXPRESSION TAG SEQADV 3ET3 SER A 196 UNP P37231 EXPRESSION TAG SEQADV 3ET3 SER A 197 UNP P37231 EXPRESSION TAG SEQADV 3ET3 GLY A 198 UNP P37231 EXPRESSION TAG SEQADV 3ET3 LEU A 199 UNP P37231 EXPRESSION TAG SEQADV 3ET3 VAL A 200 UNP P37231 EXPRESSION TAG SEQADV 3ET3 PRO A 201 UNP P37231 EXPRESSION TAG SEQADV 3ET3 ARG A 202 UNP P37231 EXPRESSION TAG SEQADV 3ET3 GLY A 203 UNP P37231 EXPRESSION TAG SEQADV 3ET3 SER A 204 UNP P37231 EXPRESSION TAG SEQADV 3ET3 HIS A 205 UNP P37231 EXPRESSION TAG SEQADV 3ET3 MET A 206 UNP P37231 EXPRESSION TAG SEQRES 1 A 292 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 292 LEU VAL PRO ARG GLY SER HIS MET GLU SER ALA ASP LEU SEQRES 3 A 292 ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SEQRES 4 A 292 SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU SEQRES 5 A 292 THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR SEQRES 6 A 292 ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS SEQRES 7 A 292 PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU SEQRES 8 A 292 VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER SEQRES 9 A 292 VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER SEQRES 10 A 292 ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL SEQRES 11 A 292 THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR SEQRES 12 A 292 MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SEQRES 13 A 292 SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SEQRES 14 A 292 SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS SEQRES 15 A 292 PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP SEQRES 16 A 292 ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SEQRES 17 A 292 SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE SEQRES 18 A 292 GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU SEQRES 19 A 292 GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE SEQRES 20 A 292 ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE SEQRES 21 A 292 VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS SEQRES 22 A 292 THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU SEQRES 23 A 292 ILE TYR LYS ASP LEU TYR SEQRES 1 P 16 HIS SER SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG SEQRES 2 P 16 LEU LEU GLN HET ET1 A 1 27 HETNAM ET1 3-{5-METHOXY-1-[(4-METHOXYPHENYL)SULFONYL]-1H-INDOL-3- HETNAM 2 ET1 YL}PROPANOIC ACID FORMUL 3 ET1 C19 H19 N O6 S FORMUL 4 HOH *217(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 GLY A 239 1 11 HELIX 3 3 ASP A 251 GLU A 259 1 9 HELIX 4 4 GLU A 276 ILE A 303 1 28 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 LEU A 333 1 24 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 ARG A 357 ASP A 362 1 6 HELIX 9 9 MET A 364 ALA A 376 1 13 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 THR A 459 1 30 HELIX 13 13 HIS A 466 LYS A 474 1 9 HELIX 14 14 SER P 682 HIS P 687 1 6 HELIX 15 15 HIS P 687 GLN P 695 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N PHE A 247 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SITE 1 AC1 15 ILE A 281 PHE A 282 CYS A 285 ARG A 288 SITE 2 AC1 15 SER A 289 HIS A 323 TYR A 327 PHE A 363 SITE 3 AC1 15 MET A 364 LYS A 367 HIS A 449 LEU A 453 SITE 4 AC1 15 TYR A 473 HOH A 627 HOH A 662 CRYST1 52.853 86.671 122.135 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018920 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011538 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008188 0.00000